Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05642364 · ClinicalTrials.gov registry record · NA
Virtual Reality in Hemodialysis to Improve Psychological Well-being
A NA study of Depressive Symptoms and End-Stage Kidney Disease, sponsored by University of Illinois at Urbana-Champaign.
- Active
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 3
- Study locations
NCT05642364: Active NA study of Depressive Symptoms and End-Stage Kidney Disease, sponsored by University of Illinois at Urbana-Champaign.
NCT05642364 is a NA study of Depressive Symptoms and End-Stage Kidney Disease that is active but no longer recruiting, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 61 participants, below the 261-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05642364, a NA study of Depressive Symptoms and End-Stage Kidney Disease, is active but no longer recruiting, sponsored by University of Illinois at Urbana-Champaign.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 3
- Study locations
Study Summary
The long-term goal is to create behavioral health technologies to advance the science that leverages state-of-the-art technology to delivery psychotherapeutic treatment to individuals on hemodialysis (HD) to improve their emotional well-being, quality of life, and overall health. The objective in this small R01 study is to design a virtual reality (VR) platform, that fully immerses users into a fictitious lifelike environment, to deliver an evidence-based positive psychological intervention and to test whether it improves the emotional well-being of individuals on HD with comorbid depression. In this proposed 2-arm randomized controlled trial, the investigators hypothesize that delivery of psychotherapy in individuals on HD using a VR environment will prove feasible and will result in significant improvements in depressive symptoms, quality of life, and treatment adherence, along with reduced rates of hospitalization when compared to an active control condition-all while serving as a cost-effective and far-reaching platform for expansive dissemination. The Specific Aims are: Aim #1: To develop VR software to immersively deliver the skills taught in a 5-week evidence-based positive psychological intervention in individuals on HD to improve their emotional well-being. Aim #2: To evaluate the acceptability and feasibility of a 5-week positive psychological intervention, delivered using a VR platform through consideration of rates of recruitment, refusal, retention, (non)compliance, and adherence. Aim #3: To test initial efficacy of the VR-based psychotherapeutic intervention, compared to a control arm, on outcomes of depression, psychological well-being, quality of life, treatment adherence, HD sessions missed, and hospitalizations in HD patients. Knowledge gained from completion of the proposed research will result in the first VR software application to deliver psychotherapy to individuals on HD, while simultaneously allowing them to leave the confines of the cl
Primary Outcome
Proportion of potential enrollees who were approached for recruitment.
Conditions Studied
Interventions
- BEHAVIORAL Joviality(TM)
- OTHER Inert Virtual Reality
Study Locations (3)
Illinois
- DaVita Little Village Dialysis PD - Chicago
- UI Health - Dialysis Unit, EEI Suite 2028 - Chicago
- DaVita Garfield Kidney Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2023-06-22 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT05642364 still lists
NCT05642364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 261-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (77% lower).
The record links to 2 conditions, with Depressive Symptoms appearing as the primary indexed condition, and to 2 interventions - of which Joviality(TM) is the first listed.
NCT05642364 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05642364 about?
NCT05642364 is a clinical study titled "Virtual Reality in Hemodialysis to Improve Psychological Well-being". The long-term goal is to create behavioral health technologies to advance the science that leverages state-of-the-art technology to delivery psychotherapeutic treatment to individuals on hemodialysis (HD) to improve their emotional well-being, quality of life, and overall health. The objective in th...
What is the current status of trial NCT05642364?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 61 participants. The study started on 2023-06-22. Estimated completion is 2026-03-31.
What conditions does trial NCT05642364 study?
This clinical trial studies the following conditions: Depressive Symptoms, End-Stage Kidney Disease.
What interventions are being tested in trial NCT05642364?
The interventions under investigation include: Joviality(TM) (BEHAVIORAL), Inert Virtual Reality (OTHER).
Who is sponsoring clinical trial NCT05642364?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05642364 being conducted?
This trial has 3 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05642364's enrollment target sits among peer trials
61 41st of 60 higher than 20 of 60 other Depressive Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Mood and Thought Process Study
RECRUITING · NA
-
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
RECRUITING · NA
-
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
RECRUITING · NA
-
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI